Stock Updates

Today’s Top Gainers in the Market Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Healthcare

Today’s top gainers include the company Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) which is in the industry Biotechnology, gaining -0.19% today. In the last week its performance is -0.21%, and 1.07% for the past quarter. Currently, Vertex Pharmaceuticals Incorporated, VRTX has a target price of 110.32, so today’s gain of -0.19% is a significant step towards its target price. The GAP today is therefore 0.02%.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), has a market cap of 23597.9, and is based in USA. Insider ownership is at 0.30%, and institutional ownership is 97.90%.

At the current price of 95.6, it has a dividend yield of *TBA, and its target price is 110.32. This is with a profit margin of -17.70%, and total debt/equity of 0.84. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has a P/E of *TBA, as well as a forward P/E of 31.05.

With a current EPS of -1.13, and a forecasted EPS growth for next year at 196.06%,Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has had a EPS growth for the past five years at 9.30%. For the next five years EPS growth is projected to be 53.63%.

Performance for the year is -28.18%. Since its IPO date on 7/24/1991, the total performance to date is -24.02%.

Volume today for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), is 928256, while its average volume is 1314.62. Whilst the total gain today was -0.19%, it did have a day high of -7.84%.

Volatility for this week has been at 2.25%, and 2.43% for the month. The 52-week low for Vertex Pharmaceuticals Incorporated, VRTX has been 25.96%, while the 52-week-high has reached -30.20%.

Looking at its return of investments, which is -28.20%, and its return on assets is -11.00%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has an operating margin of -8.70%. With a sales growth of 159.80% quarter over quarter. Bearing in mind that Vertex Pharmaceuticals Incorporated, VRTX is in the sector Healthcare, its long-term debt/equity is 0.59, and has a current ratio of 2.3 and 2.2 for quick ratio.

So what is the value of Vertex Pharmaceuticals Incorporated? Well its PEG is *TBA, and the P/S is 15.15, along with a P/B of 23.84. Meanwhile it has a p/cash of 22.02.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment